Abstract:Studies from recent years have identified a diverse population of both bacteria and fungi in the human vagina and several community signatures have emerged that are associated with susceptibility to infectious disease. A healthy vaginal bacterial microbiome is most frequently dominated by Lactobacillus species [1], yet a combination of other genera are isolated in vaginal swabs in both healthy and diseased states. The vaginal fungal mycobiome is dominated by Ascomycota, of which Candida species are the most abundant. Approximately 20% to 30% of healthy human vaginal samples contain detectable Candida at a single time point, with nearly all of those being C . albicans , and 70% of the population is expected to be vaginally colonized with Candida longitudinally [2]. Despite its prevalence in the healthy vaginal mycobiome, C . albicans is the most common causative agent of vulvovaginal candidiasis (VVC), a cause of significant morbidity in the human population. The next most common species implicated in VVC is C . glabrata , while other species including C . lusitaniae , C . tropicalis , C . parapsilosis , and C . krusei are also known to contribute to vaginal infections [3–5]. Non- albicans Candida species are typically more resistant to antifungal drugs than C . albicans [6], complicating therapeutic options and increasing treatment timelines. A disease state is often distinguished by an exaggerated inflammatory response at the vaginal mucosa [3] that leads to vulvar pruritis and erythema [7]. Polymorphic Candida species can initiate the process of filamentation, morphogenesis from single-celled yeast to multicellular hyphae, which is typically accompanied by increased tissue damage and inflammation [8]. Microbial dysbiosis has long been associated with VVC due to the observation that antibiotic usage dramatically increases the risk of onset. This notion has been challenged by several population studies [9,10]; however, other studies have found a close association between Candida and specific bacteria as well as distinct Lactobacillus species that were associated with decreased observation of fungi in samples or symptomatic VVC [11–15]. Taken together, the evidence suggests that specific bacterial species can have complex impacts on fungal burden and symptomatic infection. Shifts in the vaginal microbiome are also associated with other genital tract infections [13,16] including bacterial vaginosis (BV) and aerobic vaginitis (AV), which are characterized by the displacement of Lactobacillus species by other bacteria such as Gardnerella vaginalis , Streptococcus agalactiae , Staphylococcus aureus , Escherichia coli , and Enterococcus faecalis [17]. Both BV and AV are polymicrobial in nature and are associated with concurrent Candida carriage in many cases [18,19]. Mixed vaginitis, which can include BV or AV together with VVC, is particularly difficult to treat, and during late stages of pregnancy can lead to severe adverse maternal and neonatal outcomes [17,20]. Because it is the most abundant fungal genus in the vagina, this review will focus on the interactions between Candida species and the healthy and pathogenic bacteria found in the vaginal environment. These interactions play a significant role in maintaining homeostasis as well as impacting disease pathogenesis in the genital tract (Fig 1).

Host and Microbiome Interplay Shapes the Vaginal Microenvironment

Host-vaginal microbiota interaction: shaping the vaginal microenvironment and bacterial vaginosis

Vaginal and tumor microbiomes in gynecological cancer (Review)

The Vaginal Microenvironment: The Physiologic Role of Lactobacilli

Impact of interkingdom microbial interactions in the vaginal tract

Vaginal microecological characteristics of women in different physiological and pathological period

The Interplay Between Microbiota, Metabolites, Immunity During BV

Vaginal Microbiome: Environmental, Biological, and Racial Influences on Gynecological Health Across the Lifespan

Determinants of Vaginal Microbiota Composition

Fertility factors affect the vaginal microbiome in women of reproductive age

The Interplay Between Cervicovaginal Microbial Dysbiosis and Cervicovaginal Immunity

[Characteristics and physiologic role of female lower genital microbiome]

The human vaginal microbiota: from clinical medicine to models to mechanisms

The Interaction Between Microorganisms, Metabolites, and Immune System in the Female Genital Tract Microenvironment

Healthy Vaginal Microbiota and Influence of Probiotics Across the Female Life Span

The Female Vaginal Microbiome in Health and Bacterial Vaginosis

The association between lifestyle factors and the composition of the vaginal microbiota: a review

Crosstalk Between Female Gonadal Hormones and Vaginal Microbiota Across Various Phases of Women’s Gynecological Lifecycle

Microbiota of female genital tract - functional overview of microbial flora from vagina to uterine tubes and placenta

Harnessing the power within: engineering the microbiome for enhanced gynecologic health

The Human Microbiota in Health and Disease